These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37818687)

  • 21. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
    Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
    Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.
    Mak E; Zhou J; Tan LC; Au WL; Sitoh YY; Kandiah N
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):576-80. PubMed ID: 24133286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray Matter Atrophy in a 6-OHDA-induced Model of Parkinson's Disease.
    Kumari S; Rana B; Senthil Kumaran S; Chaudhary S; Jain S; Srivastava AK; Rajan R
    Neuroscience; 2024 Jul; 551():217-228. PubMed ID: 38843989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging techniques show that parkin gene S/N167 polymorphism is responsible for extensive brain white matter damage in patients with Parkinson's disease.
    Yu J; Shi J; Chen L; Wang Y; Cai G; Chen X; Hong W; Ye Q
    Heliyon; 2023 Aug; 9(8):e18395. PubMed ID: 37600423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
    Barrett MJ; Sperling SA; Blair JC; Freeman CS; Flanigan JL; Smolkin ME; Manning CA; Druzgal TJ
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1251-1256. PubMed ID: 31175168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-task interference during hand dexterity is a predictor for activities of daily living performance in Parkinson's disease.
    Acaröz Candan S; Özcan TŞ
    Parkinsonism Relat Disord; 2019 Sep; 66():100-104. PubMed ID: 31324554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
    Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
    Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
    Shao N; Yang J; Shang H
    Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E; Agosta F; Piramide N; Filippi M
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
    Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
    Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.
    De Vita E; Ridgway GR; White MJ; Porter MC; Caine D; Rudge P; Collinge J; Yousry TA; Jager HR; Mead S; Thornton JS; Hyare H
    Neuroimage Clin; 2017; 13():89-96. PubMed ID: 27942451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global cortical atrophy may be associated with fatigue in patients with parkinson's disease.
    Lu ZH; Chen YK; Fu XL; Liu YL; Qu JF; Xiao WM
    J Clin Neurosci; 2020 Sep; 79():172-177. PubMed ID: 33070891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.